Naomi Went

Title: Naomi Went: Innovator in Pharmaceutical Compositions

Introduction

Naomi Went is a prominent inventor based in Didcot, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of 6 patents to her name, her work is paving the way for innovative treatments.

Latest Patents

One of Naomi's latest patents focuses on Kynurenine-3-monooxygenase (KMO) inhibitors. This patent details pharmaceutical compositions and methods of use for certain compounds, including pharmaceutically acceptable salts or prodrugs. The methods described aim to treat patients suffering from diseases responsive to the inhibition of KMO activity, such as neurodegenerative disorders like Huntington's disease. The patent outlines various treatment methods, including administering the compounds as single active agents or in combination with other therapeutic agents. Additionally, it provides methods for screening compounds capable of inhibiting KMO activity.

Career Highlights

Naomi is currently associated with the CHDI Foundation, Inc., where she continues her research and development efforts. Her work is instrumental in advancing the understanding and treatment of complex diseases.

Collaborations

Naomi collaborates with notable colleagues, including Leticia M Toledo-Sherman and Celia Dominguez. These partnerships enhance the research efforts and contribute to the innovative solutions being developed.

Conclusion

Naomi Went's contributions to pharmaceutical innovations are noteworthy, particularly in the area of KMO inhibitors. Her ongoing work at the CHDI Foundation, Inc. and her collaborations with esteemed colleagues further solidify her impact in the field.